BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25762375)

  • 1. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
    Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
    Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
    Ren TH; Lv MM; An XM; Leung WK; Seto WK
    J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor.
    Wu W; He Y; Feng X; Ye S; Wang H; Tan W; Yu C; Hu J; Zheng R; Zhou Y
    Oncotarget; 2017 Jan; 8(1):705-721. PubMed ID: 27893428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
    Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
    Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells.
    Mlejnek P; Dolezel P; Kosztyu P
    J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction.
    Hussain A; Gharanei AM; Nagra AS; Maddock HL
    Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis.
    Lee HT; Kim M; Joo JD; Gallos G; Chen JF; Emala CW
    Am J Physiol Regul Integr Comp Physiol; 2006 Oct; 291(4):R959-69. PubMed ID: 16728466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased A3AR-dependent vasoconstriction in diabetic mice is promoted by myeloperoxidase.
    Nishat S; Klinke A; Baldus S; Khan LA; Basir SF
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):465-72. PubMed ID: 25000478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of adenosine A3 receptor alleviates TNF-α-induced inflammation through inhibition of the NF-κB signaling pathway in human colonic epithelial cells.
    Ren T; Qiu Y; Wu W; Feng X; Ye S; Wang Z; Tian T; He Y; Yu C; Zhou Y
    Mediators Inflamm; 2014; 2014():818251. PubMed ID: 24864134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells.
    Lee JY; Jhun BS; Oh YT; Lee JH; Choe W; Baik HH; Ha J; Yoon KS; Kim SS; Kang I
    Neurosci Lett; 2006 Mar; 396(1):1-6. PubMed ID: 16324785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
    Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
    Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A3 Adenosine Receptor Agonist Inhibited Survival of Breast Cancer Stem Cells via GLI-1 and ERK1/2 Pathway.
    Jafari SM; Panjehpour M; Aghaei M; Joshaghani HR; Enderami SE
    J Cell Biochem; 2017 Sep; 118(9):2909-2920. PubMed ID: 28230290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A3 receptor activation inhibits pronociceptive N-type Ca2+ currents and cell excitability in dorsal root ganglion neurons.
    Coppi E; Cherchi F; Fusco I; Failli P; Vona A; Dettori I; Gaviano L; Lucarini E; Jacobson KA; Tosh DK; Salvemini D; Ghelardini C; Pedata F; Di Cesare Mannelli L; Pugliese AM
    Pain; 2019 May; 160(5):1103-1118. PubMed ID: 31008816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis.
    Mabley J; Soriano F; Pacher P; Haskó G; Marton A; Wallace R; Salzman A; Szabó C
    Eur J Pharmacol; 2003 Apr; 466(3):323-9. PubMed ID: 12694816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
    Tian Y; Marshall M; French BA; Linden J; Yang Z
    Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
    Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A
    J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release.
    Varani K; Padovan M; Vincenzi F; Targa M; Trotta F; Govoni M; Borea PA
    Arthritis Res Ther; 2011; 13(6):R197. PubMed ID: 22146575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo.
    Butler M; Sanmugalingam D; Burton VJ; Wilson T; Pearson R; Watson RP; Smith P; Parkinson SJ
    Eur J Immunol; 2012 Dec; 42(12):3358-68. PubMed ID: 23027555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.